172 related articles for article (PubMed ID: 38029156)
21. Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma.
Li F; Fan YC; Gao S; Sun FK; Yang Y; Wang K
Genes Chromosomes Cancer; 2014 Jan; 53(1):90-7. PubMed ID: 24142767
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Wu M; Liu Z; Li X; Zhang A; Li N
Onco Targets Ther; 2020; 13():827-840. PubMed ID: 32095079
[TBL] [Abstract][Full Text] [Related]
23. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
24. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
[TBL] [Abstract][Full Text] [Related]
25. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian CH; Dai J; Zhang W; Liu Y; Yang Y
Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
[TBL] [Abstract][Full Text] [Related]
26. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P
Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511
[TBL] [Abstract][Full Text] [Related]
28. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
[No Abstract] [Full Text] [Related]
29. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
32. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
Yang T; Wang N; Wang F; Liu H; Shen F; Lv G
BMJ Open; 2023 Sep; 13(9):e076467. PubMed ID: 37723113
[TBL] [Abstract][Full Text] [Related]
33. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.
Li GJ; Chen QY; Harrison TJ; Wang XY; Hu LP; Yang QL; Li KW; Fang ZL
Cancer Biomark; 2017; 18(3):241-248. PubMed ID: 28085009
[TBL] [Abstract][Full Text] [Related]
34. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
35. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
36. Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection.
Ye F; Huang W; Xue Y; Tang E; Wang M; Shi F; Wei D; Han Y; Chen P; Zhang X; Yu D
J Hepatocell Carcinoma; 2021; 8():285-300. PubMed ID: 33948441
[TBL] [Abstract][Full Text] [Related]
37. Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases.
Sun L; Li K; Liu G; Xu Y; Zhang A; Lin D; Zhang H; Zhao X; Jin B; Li N; Zhang Y
Cancer Med; 2018 Oct; 7(10):5178-5186. PubMed ID: 30259695
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma.
Zhao NH; Qian Y; Wu CS; Wang JW; Fang Y; Fan XP; Gao S; Fan YC; Wang K
Biomark Med; 2019 Sep; 13(13):1093-1105. PubMed ID: 31411040
[No Abstract] [Full Text] [Related]
39. Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Elsewify WAE; Hassan EA; Mekky MA; Abd El-Rehim ASE; Sayed ZEA; Abdel Malek MO; ElMelegy TTH; Sabry A
Int J Gen Med; 2020; 13():147-155. PubMed ID: 32431531
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
